See other companies on Welcome to the Jungle

Sano Genetics

Personalised health research

Sano Genetics logo
21-100 employees
  • Healthcare
  • B2C
  • Big data
  • Biology
  • SaaS
  • MedTech
Cambridge, UK

Company mission

To accelerate the future of personalised medicine.

Led by a woman
Top investors

49% female employees

50% employee growth in 12 months

Our take

Unlocking the potential of personalised medicine would lead to tremendous progress in treating many diseases. Sano Genetics is working towards making this a reality through a user-centric genetic data marketplace that connects individuals directly to medical research institutions, acting as ethical brokers to facilitate a direct connection between individuals and research institutions.

This provides access to dynamic health and genetic data for genomics research to accelerate the pace of precision medicine, whilst promoting transparency and data privacy for participants. Anyone can sign up for the platform for free and participants gain access to cutting-edge medical reports on conditions relevant to them receive personalised genetic reports, and have the option to participate in research studies and clinical trials. Sano offers participants full transparency and control over how their data is used.

The company's current focus is on neurological and immune conditions - Parkinson’s Disease, Multiple Sclerosis, and Long COVID, amongst others. Sano expanded its product to be a 'patient portal' for national-scale precision medicine initiatives, such as Genomics England, with the potential to impact millions of people. In 2024, its funding raise of $11.4 million is being channelled into scaling its product to meet demand globally and developing AI integrations.

Freddie headshot

Freddie

Company Specialist at Welcome to the Jungle

Benefits

  • Full health insurance with access to all UK private hospitals/specialists with zero excess (possibility to add family members at reduced price)
  • Life & Income protection insurance
  • 16 Weeks Full Pay Parental Leave (for both mothers and fathers)

Company values

  • Transparency is key. We value honesty with our colleagues, users, customers, and partners, and we're prepared to explain any secrets
  • Impact matters. We're focused on building things that truly help individuals, society, and the world. We might not be everything to everyone, but we can change lives
  • Collaboration is crucial. We value fresh perspectives and encourage feedback from everyone. We listen and are curious about what makes each other tick
  • Empathy drives us. We put ourselves in the shoes of our patients, clients, and team members. We're careful to consider all viewpoints and assess the consequences of our actions
  • Accountability is everything. We take responsibility for our actions and prioritize making things right for our users, customers, and employees
  • Choose Positivity! We welcome ideas, even difficult ones, and provide constructive alternatives. We're not here to undermine each other, but to move things forward

Funding (last 2 of 7 rounds)

Jan 2024

$11.4m

EARLY VC

Aug 2023

$0.5m

GRANT

Total funding: $26.6m

This company has top investors

Leadership

Patrick Short

(CEO & Co-Founder)

Experience in genomics and rare genetic disorders research at the Wellcome Trust Sanger Institute and the University of Cambridge.

Charlotte Guzo

(COO & Co-Founder)

Co-Founder and COO @Sano Genetics. Previous risk analyst at JP Morgan. PhD at University of Cambridge.

Computer scientist previously working on deep learning and genetics at the Wellcome Trust Sanger Institute and the University of Cambridge.

People progressing

Hamzah joined Sano as a Frontend Developer in 2020, and after three years he earned a promotion to Frontend Team Lead. In 2024, Hamzah will be managing a team of six.

Marisa joined Sano in March 2023 as a Product Designer. After just 8 months with the company, her role changed and she was promoted to Product Manager, then Senior Product Manager.

Diversity, Equity & Inclusion at Sano Genetics

Chantelle Ebhogiaye headshot

Chantelle Ebhogiaye (People Operations Manager )

  • Our platform is built with diversity and inclusion at its foundation, empowering pharmaceutical and biotechnology companies to adopt a more inclusive approach to clinical trials, encompassing geographical and ethnic diversity. Our vision is to become the leading provider of ethical genomic and health data for precision medicine development.
  • As an employer, we're committed to fostering a diverse and inclusive work environment. While we're still in the early stages of our DE&I journey, our approach is deeply embedded in our core values, reflected in our hiring processes, company culture, and workplace policies.
  • We prioritise a diverse pipeline of candidates by employing methods like the Rooney Rule. Additionally, we gather meaningful data during the application and onboarding phases to track our hiring data, allowing us to identify and address areas for improvement.
  • 2024 is a big year for Sano's DE&I efforts. We're spearheading initiatives to enhance our inclusivity, including implementing a blind hiring process to eliminate unconscious bias from our hiring decisions. We're also developing a mentorship program to support new joiners and establishing a diversity and inclusion committee to oversee our DE&I endeavours.
  • Moreover, we're introducing interview training to eliminate bias and further strengthen our commitment to creating a truly inclusive workplace.

Endorsements

All

Flexible working (5)

Career progression (3)

Meaningful work (3)

Open and honest communication (3)

Autonomy (2)

Nice people (2)

Focus on employee wellbeing (2)

Opportunities to learn (1)

Intelligent people (1)

My opinions are valued (1)

Sano Genetics 1Sano Genetics 2Sano Genetics 3Sano Genetics 4Sano Genetics 5Sano Genetics 6Sano Genetics 7Sano Genetics 8Sano Genetics 9Sano Genetics 10